{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:57:39Z","timestamp":1780775859270,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T00:00:00Z","timestamp":1277164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s13277-010-0062-4","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:04:49Z","timestamp":1277078689000},"page":"495-502","source":"Crossref","is-referenced-by-count":9,"title":["Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16)"],"prefix":"10.1007","volume":"31","author":[{"given":"Zach T.","family":"Berman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Knudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,22]]},"reference":[{"key":"62_CR1","unstructured":"American Cancer Society: All about ovarian cancer. http:\/\/www.cancer.org (2009)."},{"key":"62_CR2","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","volume":"68","author":"RC Bast","year":"1981","unstructured":"Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331\u20137.","journal-title":"J Clin Invest"},{"key":"62_CR3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","volume":"309","author":"RC Bast","year":"1983","unstructured":"Bast RC, Klug TL, St. John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309:883\u20137.","journal-title":"N Engl J Med"},{"key":"62_CR4","doi-asserted-by":"crossref","first-page":"200s","DOI":"10.1200\/JCO.2003.01.068","volume":"21","author":"RC Bast","year":"2003","unstructured":"Bast RC. Status of tumor markers in ovarian cancer screening. J Clin Oncol. 2003;21:200s\u20135s.","journal-title":"J Clin Oncol"},{"key":"62_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-2-13","volume":"2","author":"D Gupta","year":"2009","unstructured":"Gupta D, Lis CG. Role of CA125 in predicting ovarian cancer survival\u2014a review of the epidemiological literature. J Ovarian Res. 2009;2:13.","journal-title":"J Ovarian Res"},{"issue":"suppl 3","key":"62_CR6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","volume":"15","author":"RC Bast","year":"2005","unstructured":"Bast RC, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, et al. New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005;15 suppl 3:274\u201381.","journal-title":"Int J Gynecol Cancer"},{"key":"62_CR7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2007.08.009","volume":"107","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Yu Y, Xu F, Berchuck A, van Haaften-Day C, Havrilesky LJ, et al. Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. Gynecol Oncol. 2007;107:526\u201331.","journal-title":"Gynecol Oncol"},{"key":"62_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000050638","volume":"22","author":"TJ O\u2019Brien","year":"2001","unstructured":"O\u2019Brien TJ, Beard JB, Underwood LJ, Dennis RA, Santin AD, York L. The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumor Biol. 2001;22:348\u201366.","journal-title":"Tumor Biol"},{"key":"62_CR9","doi-asserted-by":"crossref","first-page":"27371","DOI":"10.1074\/jbc.M103554200","volume":"276","author":"BWT Yin","year":"2001","unstructured":"Yin BWT, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001;276:27371\u20135.","journal-title":"J Biol Chem"},{"key":"62_CR10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000064032","volume":"23","author":"TJ O\u2019Brien","year":"2002","unstructured":"O\u2019Brien TJ, Beard JB, Underwood LJ, Shigemasa K. The CA 125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumor Biol. 2002;23:154\u201369.","journal-title":"Tumor Biol"},{"key":"62_CR11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ijc.10250","volume":"98","author":"BWT Yin","year":"2002","unstructured":"Yin BWT, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer. 2002;98:737\u201340.","journal-title":"Int J Cancer"},{"key":"62_CR12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.physiol.70.113006.100659","volume":"70","author":"CL Hattrup","year":"2008","unstructured":"Hattrup CL, Gendler SJ. Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol. 2008;70:431\u201357.","journal-title":"Annu Rev Physiol"},{"key":"62_CR13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1470-2045(08)70277-8","volume":"9","author":"AP Singh","year":"2008","unstructured":"Singh AP, Senapati S, Ponnusamy MP, Jain M, Lele SM, Davis JS, et al. Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. Lancet Oncol. 2008;9:1076\u201385.","journal-title":"Lancet Oncol"},{"issue":"suppl 1","key":"62_CR14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000056502","volume":"19","author":"S Imai","year":"1998","unstructured":"Imai S, Haga S, Kiyozuka Y. Epitope characterization of MUC1 antibodies. Tumor Biol. 1998;19 suppl 1:30\u20134.","journal-title":"Tumor Biol"},{"issue":"suppl 1","key":"62_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000056503","volume":"19","author":"DJ Schol","year":"1998","unstructured":"Schol DJ, Meulenbroek MFA, Snijdewint FGM, von Mensdorff-Pouilly S, Verstraeten RA, Murakami F, et al. \u201cEpitope fingerprinting\u201d using overlapping 20-mer peptides of the MUC1 tandem repeat sequence. Tumor Biol. 1998;19 suppl 1:35\u201345.","journal-title":"Tumor Biol"},{"key":"62_CR16","doi-asserted-by":"crossref","first-page":"9946","DOI":"10.1021\/bi012176z","volume":"41","author":"JS Grinstead","year":"2002","unstructured":"Grinstead JS, Koganty RR, Krantz MJ, Longenecker BM, Campbell AP. Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide\u2013antibody interactions. Biochem. 2002;41:9946\u201361.","journal-title":"Biochem"},{"key":"62_CR17","first-page":"5386","volume":"53","author":"JD Fontenot","year":"1993","unstructured":"Fontenot JD, Tjandra N, Bu D, Ho C, Montelaro RC, Finn OJ. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core. Cancer Res. 1993;53:5386\u201394.","journal-title":"Cancer Res"},{"key":"62_CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000096085","volume":"27","author":"CSM Ferreira","year":"2006","unstructured":"Ferreira CSM, Matthews CS, Missailidis S. DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumor Biol. 2006;27:289\u2013301.","journal-title":"Tumor Biol"},{"key":"62_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000209988","volume":"30","author":"DJ Warren","year":"2009","unstructured":"Warren DJ, Nustad K, Beard JB, O\u2019Brien TJ. Expression and epitope characterization of a recombinant CA 125 repeat: fourth report from the ISOBM TD-1 workshop. Tumor Biol. 2009;30:51\u201360.","journal-title":"Tumor Biol"},{"key":"62_CR20","volume-title":"Fmoc solid phase peptide synthesis: a practical approach","year":"2000","unstructured":"Chan WC, White PD, editors. Fmoc solid phase peptide synthesis: a practical approach. New York: Oxford University Press; 2000."},{"key":"62_CR21","volume-title":"Introduction to modern vibrational spectroscopy","author":"M Diem","year":"1993","unstructured":"Diem M. Introduction to modern vibrational spectroscopy. New York: John Wiley and Sons; 1993."},{"key":"62_CR22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/S0033583502003815","volume":"35","author":"A Barth","year":"2002","unstructured":"Barth A, Zscherp C. What vibrations tell us about proteins. Q Rev Biophys. 2002;35:369\u2013430.","journal-title":"Q Rev Biophys"},{"key":"62_CR23","doi-asserted-by":"crossref","first-page":"13174","DOI":"10.1074\/jbc.M309417200","volume":"279","author":"T Maeda","year":"2004","unstructured":"Maeda T, Inoue M, Koshiba S, Yabuki T, Aoki M, Nunokawa E, et al. Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16). J Biol Chem. 2004;279:13174\u201382.","journal-title":"J Biol Chem"},{"key":"62_CR24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","volume":"5","author":"JAA Gubbels","year":"2006","unstructured":"Gubbels JAA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, et al. Mesothelin-MUC16 binding is a high-affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol Cancer. 2006;5:50.","journal-title":"Mol Cancer"},{"key":"62_CR25","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1074\/jbc.M806776200","volume":"284","author":"O Kaneko","year":"2009","unstructured":"Kaneko O, Gong L, Zhang J, Hansen JK, Hassan R, Lee B, et al. A binding domain on mesothelein for CA125\/MUC16. J Biol Chem. 2009;284:3739\u201349.","journal-title":"J Biol Chem"},{"key":"62_CR26","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1158\/0008-5472.CAN-06-4512","volume":"67","author":"Y Chen","year":"2007","unstructured":"Chen Y, Clark S, Wong T, Chen Y, Chen Y, Dennis MS, et al. Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models. Cancer Res. 2007;67:4924\u201332.","journal-title":"Cancer Res"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-010-0062-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-010-0062-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-010-0062-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:24:32Z","timestamp":1559489072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-010-0062-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,22]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s13277-010-0062-4","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,22]]}}}